Cellectis proposes follow-on

Cellectis S.A. (Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date announced: 2015-01-08 Type: Follow-on To be raised: TBD Shares: TBD Price prior: EUR19.10 Note: Cellectis is s...